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Edited by Aleksander BenjakAbstract Nitric oxide (NO), generated by NO synthases
(NOSs), has multifarious roles in signal transduction. Reactive
oxygen species (ROS), generated by ubiquitous NADPH oxi-
dases (NOXs), also participate in cellular signaling. However,
the coordination of signals conveyed by NO and ROS is poorly
understood. We show that the small GTPase Rac, a component
of some NOXs, also interacts with and regulates the constitu-
tively-expressed NOSs. Cellular NO and O2 production in-
crease or decrease together following activation or inhibition of
Rac, and Rac inhibition reveals transduction mechanisms that
depend upon NO (vasodilation), ROS (actin polymerization) or
both (cytoskeletal organization). Thus, signaling by NO and
ROS may be coordinated through a common control element.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Speciﬁc enzymatic mechanisms in mammalian cells generate
two free-radical species: nitric oxide (NO) via NO synthases
(NOS) and superoxide ðO2 Þ via NADPH oxidases (NOX).
NO, generated by NOSs that are expressed constitutively in
most cell types, regulates a wide range of physiological signals,
acting substantially through S-nitrosylation of active site and
allosteric cysteine residues [1]. NOXs as well are expressed con-
stitutively in many cell types, and their activity is coupled to
diverse physiological stimuli [2–4]. In addition, reactive oxygen
species (ROS) generated from O2 , in particular hydrogen per-
oxide (H2O2), can oxidatively modify cysteine thiols and may
thereby modulate protein function [5].Abbreviations: NO, nitric oxide; NOS, nitric oxide synthase; ROS,
reactive oxygen species; NOX, NADPH oxidase; eNOS, endothelial
nitric oxide synthase; iNOS, induced nitric oxide synthase; nNOS,
neauronal nitric oxide synthase
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doi:10.1016/j.febslet.2008.04.062The extent and mechanisms of interaction between redox-
based cellular signals conveyed by NO and ROS remain major
unresolved issues, and it has been assumed that NO and O2
are mutually eliminative in vivo [6,7]. We report here that
the small GTPase Rac, a component of at least some major
forms of NOX [2–4,8], also interacts with and regulates the
activity of the constitutively-expressed NOSs (endothelial
NOS, eNOS, and neuronal NOS, nNOS), and that NO and
O2 production are altered in parallel, and not in opposition,
by inhibition or activation of Rac. Furthermore, we demon-
strate a role for Rac in transduction that utilizes NO, ROS
or both.2. Materials and methods
Additional materials and methods can be found on-line as Supple-
mentary material.
2.1. Reagents for manipulation of Rac and Nox activity
Mutant human Rac 1 was overexpressed in cultured cells as either
Rac 1 G12V (Rac-CA), in which turnover of bound GTP is greatly
reduced and which is therefore constitutively active (Rac-CA), or as
Rac 1 D17N, in which GDP is preferentially bound and which
therefore functions as a dominant negative suppressor of endogenous,
Rac-dependent mechanisms when overexpressed (Rac-DN). Since their
use was introduced in the context of analyzing the role of Rac in cyto-
skeletal regulation [9], Rac-CA and Rac-DN have been employed
extensively in a broad range of studies examining many eﬀects of
Rac activity in cultured cells (e.g., [10]).
For acute, pharmacological inhibition of Rac, we employed a spe-
ciﬁc small-molecule inhibitor of Rac activation, NSC23766 (NSC).
NSC, which was identiﬁed by structure-based virtual screening, acts
as a competitive inhibitor to prevent binding to and activation of
Rac by Rac-speciﬁc GEFs including Trio and Tiam1 [11].
For speciﬁc inhibition of Nox activity, we employed a peptide
inhibitor of NOX activation (gp91 ds-tat) and a control peptide
(scram-tat). The gp91 ds (docking sequence)-tat peptide comprises a
segment of the region within the catalytic ﬂavocytochrome subunit
of NOX2 (gp91phox) to which p47phox binds, fused to the HIV tat se-
quence to facilitate entry into cells, and gp91 ds-tat blocks the activat-
ing interaction between p47phox and gp91phox (and/or their close
homologues) [12]. The gp91 ds sequence was scrambled in the scram-
tat control peptide. The peptide sequence of gp91 ds-tat is:
RKKRRQRRR (tat portion) CSTRIRRQL-NH2 (gp91 ds portion).
In the scram-tat peptide, the gp91 ds sequence is replaced with
CLRITRQSR-NH2.
In addition, we employed a well-characterized, stable, cell-permeant
superoxide dismutase (SOD) mimetic, manganese(III)5,10,15,20-tetra-
kis(N-ethylpyridinium-2-yl)porphyrin (MnTE-2-PyP5+), to accelerate
the removal of O2 ð2O2 ! H2O2Þ in cultured cells [13].blished by Elsevier B.V. All rights reserved.
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Primary human aortic endothelial cells (HAEC, Clonetics) were
cultured in serum-rich endothelial growth medium (EGM-2, Clonet-
ics) and used at passages 4–6. Cells were infected at 75% conﬂuency
by exposure for 12 h to myc-tagged adenoviral constructs of Rac-
DN or Rac-CA and maintained in fresh medium for 36 h, followed
by incubation for an additional 12 h with or without serum depriva-
tion. Under these conditions, infection eﬃciency was greater than
75% as assessed by immunohistoﬂuorescence of myc. Human embry-
onic kidney (HEK) cells stably transfected with eNOS or nNOS were
grown in Dulbeccos modiﬁed Eagles medium (DMEM) containing
10% serum, infected by exposure for 12 h to Rac-CA or Rac-DN
adenoviral constructs in medium containing 2% serum, and main-
tained in medium containing 10% serum for an additional 24 h before
analysis. Primary cultures of rat hippocampal neurons were prepared
as described from the CA1 region of day-old pups [14] and main-
tained in supplemented Neurobasal medium (Sigma) for 14 d before
NOS activity assay. When employed in measurement of NO=O2 lev-
els or of actin content/distribution, MnTE-2-PyP5+ (50 lM) and the
NOS inhibitor L-NMMA (3 mM) were applied 48 h before assay.
For speciﬁc inhibition of Rac activation with NSC, HAEC were incu-
bated with 1 mM NSC for 36 h before NOS activity assays, ring seg-
ments of rabbit thoracic aorta were incubated with 100 lM NSC for
1 h before measurement of cGMP or bioassay, and hippocampal neu-
rons were incubated with 100 lM NSC for either 1 h or 16 h before
NOS activity assay.
2.3. Measurement of intracellular NO and O2
Cells were washed in PBS and incubated for 30 min at 37 C in
Hanks balanced salt solution supplemented with 200 mM HEPES
and 5 mM glucose, and containing either 5 lM 4,5-diaminoﬂuorescein
diacetate (DAF-FM, Molecular Probes) for detection of NO or 10 lM
dihydroethidium (DHE, Molecular Probes) for detection of O2 . Cells
loaded with DAF-FM were washed and incubated for 15–30 min, and
DHE-loaded cells were washed without further incubation, before
analysis by laser-scanning confocal microscopy.3. Results
3.1. Rac1 co-regulates NO production by NOS and O2
production by NOX
On the assumption of mutual elimination, we were surprised
to ﬁnd that, in primary human aortic endothelial cells (HAEC,
which contain at least one isoform of both NOS and NOX,
including NOS3 and NOX2), expression (via an adenoviral
vector) of a dominant-negative (GDP-bound) form of Rac
(Rac1 D17N, Rac-DN), which prevented production of O2
as assessed by DHE ﬂuorescence (Fig. 1A), did not increase
but rather substantially reduced basal levels of NO as assessed
by DAF-FM ﬂuorescence (Fig. 1A). Conversely, expression of
a constitutively-active (GTP-bound) form of Rac (Rac1 G12V,
Rac-CA) resulted in large increases in both NO and O2 levels
(Fig. 1A).
Rac and other constituents including p47phox were identiﬁed
as obligate components of active multicomponent NOX
(NOX2) in phagocytic cells [2], and considerable evidence indi-
cates that at least some of these components, including Rac,
are required for NOX activity in other cell types [2–4,8]. None-
theless, eﬀects of Rac on O2 production that are independent
of NOX are possible in principle. We found that treatment of
HAEC with a peptide shown to speciﬁcally inhibit the binding
of p47phox to the membrane-associated catalytic ﬂavocyto-
chrome subunit of NOX2 (gp91phox) [12] abrogated the in-
crease in O2 production induced by Rac-CA expression and
suppressed basal O2 production, as assessed by DHE ﬂuores-
cence (Fig. 1B). These results demonstrate directly that Rac1governs O2 generation in endothelial cells by regulating the
activity of a NOX, which is dependent upon p47phox or a close
homologue, consistent with and extending previous results [2–
4,15].
Rac-dependent changes in levels of NO might be accounted
for by an eﬀect on NOS activity or abundance or on NO
metabolism. Assay of NOS function in intact cells by measur-
ing the conversion of 3H-arginine to 3H-citrulline, a speciﬁc
indicator of enzymatic activity, demonstrated directly that
expression of Rac-CA potentiated NO production by NOS
in HAEC (Fig. 1C), in the absence of changes in endothelial
NOS (eNOS) expression as assessed by western blotting or ef-
fects on cellular uptake of 3H-arginine (not shown). Further,
the Rac-dependent increase in NOS activity was unaﬀected
by eliminating hydrogen peroxide with cell-permeable polyeth-
ylene glycol (PEG)-linked catalase (as assessed by 2 0,7 0-dichlo-
rodihydroﬂuorescein diacetate ﬂuorescence, not shown), and
was thus independent of increased production of the major
reactive oxygen species resulting from NOX activity (Fig.
1B). More generally, the ﬁnding that altering Rac activity con-
comitantly increased or decreased levels of both NO and O2 is
explained by conjoint regulation by Rac of NOS and NOX,
rather than by any action of NO or O2 on production or
metabolism of the other species (or any lack of speciﬁcity in
the ﬂuorescent indicators employed [16]), because greatly
reducing O2 with the SOD mimetic, MnTE-2-PyP
5+, or NO
with the NOS inhibitor, NG-monomethyl-L-arginine
(L-NMMA), did not substantially aﬀect levels of the other spe-
cies in cells expressing Rac-CA (Fig. 1A). In addition, protein
nitrotyrosine content, a measure of peroxynitrite formation
from NO=O2 combination, was indistinguishable in control
and Rac-CA-expressing cells as assessed by western blotting
(not shown).
The predominant form of NOS in endothelial cells (includ-
ing HAEC) is eNOS. The generality of our results was demon-
strated by the ﬁnding that NO production was potentiated by
Rac-CA and inhibited by Rac-DN in HEK cells stably trans-
fected with either eNOS or nNOS (Fig. 1D). Thus, Rac can
regulate basal NO production by the major, constitutively-ex-
pressed forms of NOS. Note that, as for nNOS, NOXs are dis-
tributed broadly within the central nervous system [17].
Because mutant, overexpressed Rac might not replicate the
actions of endogenous Rac and might suppress other G-pro-
teins by eﬀectively depleting exchange factors that are not
exclusive to Rac, we veriﬁed and extended our ﬁndings by
employing a speciﬁc small-molecule inhibitor of Rac activa-
tion, NSC. NSC was reported to have no eﬀect on other clo-
sely-related members of the Rho family of G-proteins
(Cdc42, RhoA) [11]. Treatment overnight (16 h) with NSC
substantially decreased basal eNOS activity of HAEC, as well
as basal nNOS activity of cultured rodent primary hippocam-
pal neurons, and signiﬁcant decreases in nNOS activity of cul-
tured neurons were evident following even brief exposure to
NSC (1 h) (Fig. 1C). In addition, we veriﬁed that Rac exhib-
ited basal activity in HAEC (consistent with suppression of
NOS activity, and of resting NO and O2 production, by inhi-
bition of Rac) and that treatment with NSC, at concentrations
(0.1–1 mM) and over intervals (1–16 h) employed in evaluating
eﬀects on NOS activity, greatly inhibited Rac without eﬀects
on RhoA, as assessed by substrate-binding activation assays
(Fig. 1E).
Fig. 1. Rac co-regulates NO and O2 production. (A) In HAEC, NO (DAF ﬂuorescence) and O

2 (DHE ﬂuorescence) are increased by expression of
Rac-CA and decreased by expression of Rac-DN. Reducing levels of NO by inhibiting NOS (L-NMMA) or of O2 with MnTE-2-PyP
5+ (SOD
mimetic) has little eﬀect on levels of the other species. (B) Rac1 regulates endothelial O2 production by a p47
phox-dependent NADPH oxidase
(NOX). HAEC expressing Rac-CA were treated with a peptide inhibitor of NOX activation (gp91 ds-tat) or with a control peptide (scramb-tat).
Expression of Rac-CA resulted in large increases in O2 production as assessed by DHE ﬂuorescence, which were eliminated by treatment with gp91
ds-tat. Note that treatment with gp91 ds-tat also suppressed basal O2 production. For each condition, average DHE ﬂuorescence/cell (means ± S.D.)
was quantiﬁed for 1–5 cells in each of 20–24 randomly selected microscopic ﬁelds of view, obtained from three experiments in which all conditions
were examined. (C) Upper histogram: expression of Rac-CA enhances endogenous eNOS enzymatic activity in HAEC as assessed by measuring the
conversion of 3H-arginine to 3H-citrulline, and enhancement is not inﬂuenced signiﬁcantly by eliminating intracellular H2O2 with PEG-catalase
(P < 0.05; n = 3). Asterisk indicates signiﬁcant re. uninfected control. Av-null indicates adenoviral vector control. Lower histogram: treatment with a
small-molecule inhibitor of Rac activation (NSC) signiﬁcantly inhibits endogenous NOS activity of HAEC (NSC: 1 mM for 16 h) and of cultured rat
primary hippocampal neurons (NSC: 100 lM for 1 h or 16 h) (P < 0.05; n = 4 for all groups). Asterisk indicates signiﬁcant re. untreated control
cultures. (D) Levels of NO are increased by Rac-CA expression and decreased by Rac-DN expression in HEK cells stably transfected with either
eNOS or nNOS. (E) Basal activity of Rac in HAEC and speciﬁc inhibition of Rac by NSC. Cultured HAEC were exposed to NSC overnight and Rac
and RhoA activities were assessed by substrate-binding activation assays. NSC eliminates basal (Ctrl) Rac activity but has no eﬀect on RhoA
activity. Rows depict representative Western blots for Rac or RhoA following substrate binding and pulldown (top and bottom rows), or of starting
material (cell lysate; middle row).
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Basal and stimulus-induced NOS activity can be regulated
separately [18]. To determine whether Rac governs stimulus-
induced and physiologically relevant NOS activity, we
examined the eﬀects of expressing Rac-DN in endothelial cells
of intact aorta, and of exposure to NSC, on the acetylcholine
(ACh)-induced increase in smooth muscle cyclic guanosine
monophosphate (cGMP) and decrease in smooth muscle tone,
which together constitute the prototypic example of the cellu-
lar role of NO (vasodilation).
In ring segments of rabbit aorta, expression of Rac-DN,
which was restricted to the endothelium (Fig. 2A), signiﬁcantly
suppressed ACh-induced, NO-dependent production of cGMP
in smooth muscle as determined by radioimmunoassay (Fig.
2B), and smooth muscle relaxation as determined in bioassays(Fig. 2C). The proportionately greater eﬀect of Rac-DN
expression on cGMP production vs. relaxation may reﬂect a
non-linear relationship between guanylate cyclase activity
and smooth muscle tone as well as a contribution of NO-
and/or cGMP-independent mechanisms to the vasodilatory ac-
tion of ACh. Exposure of intact aortic segments to NSC also
signiﬁcantly decreased ACh-induced cGMP production (Fig.
2D) and vasorelaxation (Fig. 2E). Inhibition of vasorelaxation
was reversed rapidly following removal of NSC (Fig. 2E, in-
set). We also determined that exposure to NSC had no eﬀect
on smooth muscle contractility (no change in the contractile
response to potassium-induced depolarization) or on transduc-
tion downstream of NOS (no change in nitroglycerin-induced
relaxation) (not shown). Diﬀerences between the eﬀects of Rac-
DN and of NSC on the form of the ACh dose–response curve
Fig. 2. Suppressing Rac activity inhibits ligand-induced NOS activation. (A) In intact aorta, expression of myc-tagged Rac-DN is restricted to the
endothelium after application of the adenoviral vector to the aortic lumen (see Supplementary Materials and Methods), as revealed by myc
immunohistochemistry. (B) Radioimmunoassay shows that cGMP production induced in aortic smooth muscle by ACh (106 M) is inhibited
signiﬁcantly by endothelial expression of Rac-DN (P < 0.05; n = 6). In (B) and (C), Av-null indicates adenoviral vector control. (C) Expression of
Rac-DN in aortic endothelium signiﬁcantly inhibits ACh-induced smooth muscle relaxation (vasodilation) as assessed by bioassay of aortic ring
segments (P < 0.05 at all doses of ACh; n = 6). (D) Treatment of intact aorta with NSC (0.1 mM for 1 h), signiﬁcantly inhibits both basal and ACh-
induced cGMP production (P < 0.05; n = 5 for each group). Single asterisk indicates signiﬁcant re. unstimulated control, and double asterisks
indicate signiﬁcant re. ACh-stimulated control. (E) Treatment of intact aorta with NSC as in (D) signiﬁcantly inhibits ACh-induced vasodilation at
all doses of ACh (P < 0.05; n = 3). The eﬀect of NSC is reversed by washing (inset). (F) Treatment of HAEC with NSC (1 mM; 36 h) signiﬁcantly
inhibits both basal NOS activity and NOS activation by VEGF (100 ng/ml) (P < 0.05; n = 4 for all groups). Single asterisk indicates signiﬁcant re.
untreated control (red line = 100% of untreated control), and double asterisks indicate signiﬁcant re. VEGF. (G) Treatment of primary bovine aortic
endothelial cells with Rac1-speciﬁc siRNA, which greatly reduces levels of Rac1 (80–90%) but does not aﬀect levels of eNOS (as assessed by
Western blotting, shown at right), signiﬁcantly inhibits NOS activation by VEGF (100 ng/ml) (P < 0.05, n = 3; signiﬁcance indicated as in (F)). Note
that NOS activity is approximately doubled by VEGF stimulation, and that basal NOS activity is not aﬀected signiﬁcantly by Rac knockdown. Ctrl
siRNA = transfection with non-speciﬁc siRNA duplexes (see Supplementary Materials and Methods).
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In addition, we found that NSC signiﬁcantly inhibited stimula-tion of NOS in cultured HAEC by vascular endothelial growth
factor (VEGF) (Fig. 2F), demonstrating a role for Rac in reg-
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transduction mechanisms (G-protein coupled and receptor
tyrosine kinase).
Because NSC prevents Rac activation, the suppressive eﬀects
of NSC on stimulus-induced NOS activation should be repli-
cated by removing Rac. This prediction was conﬁrmed fully
by the ﬁnding that greatly reducing (>80%) the Rac content
of primary bovine aortic endothelial cells (BAEC) with siRNA
signiﬁcantly suppressed NOS activation by VEGF, in the ab-
sence of any changes in eNOS abundance (Fig. 2G). Note that,
in contrast to the eﬀects of Rac-DN and of sustained exposure
to NSC (which would promote Rac-GDP formation), knock-
down of Rac did not signiﬁcantly suppress basal NOS activity
(Fig. 2G). Removing Rac would not in and of itself substan-
tially alter basal NOS activity if it is the nucleotide-bound state
of Rac that determines its eﬀects on NOS (i.e., potentiation
and suppression of NOS activity by, respectively, Rac-GTP
and Rac-GDP).
3.3. Molecular interaction of Rac1 and eNOS
Ligand-induced increases in the activity of constitutively-ex-
pressed NOSs are often transitory. Sustained increases and de-
creases in basal eNOS and nNOS activity, as we observed in
HEK cells following expression of Rac-CA and Rac-DN,
could be provided by NOS phosphorylation [18]. However,Fig. 3. Molecular interaction of Rac and NOS. (A) Rac and eNOS co-elute,
with 1% NP-40, in high-mass complexes (fraction 10  650 kDa) and a pop
consistent with uncomplexed, monomeric Rac). The Western blot shown wa
Rac-CA bound to glutathione-sepharose complexes with eNOS and with nNO
and C) were generated by incubating equal quantities of extract (or of puriﬁ
binds directly to immobilized Rac-CA and wild-type Rac. Binding of eNOS t
to nucleotide-free Rac (EDTA) is substantially more eﬃcient.although we do not rule out a role for NOS phosphorylation,
we did not detect changes in phosphorylation of eNOS in wes-
tern blots of extracts from Rac-CA-expressing HAEC using
antibodies speciﬁc for phospho-Ser1177 or phospho-Ser116
(not shown), two sites where eNOS phosphorylation is altered
by multiple physiological stimuli [18]. We therefore considered
the possibility that Rac and constitutively-expressed NOSs
form a complex in which Rac serves as an allosteric regulator
of NOS activity, as suggested previously for iNOS (NOS2)
[19]. Co-elution of Rac and eNOS in size-exclusion chromatog-
raphy of HAEC extracts indicated co-localization in macro-
molecular complexes, although the large complex masses
indicate the presence of other elements (Fig. 3A). More di-
rectly, we found that glutathione-S-transferase (GST)-tagged
Rac-CA, immobilized on glutathione-sepharose, complexed
with eNOS and with nNOS, respectively, in extracts of eNOS-
or nNOS- transfected HEK cells (Fig. 3B), and with eNOS in
extracts of HAEC (Supplementary Fig.). In addition, Rac-CA
brought down eNOS from HAEC extracts of perinuclear and
plasma membranes with comparable eﬃcacy; thus, Rac may
regulate NO production by eNOS in both compartments
where it is concentrated (Supplementary Fig.). These ﬁndings
are generally consistent with Kone et al. [19], who reported
that Rac and iNOS interact in macrophages following induc-
tion of iNOS with bacterial lipopolysaccharide, althoughin size-exclusion chromatography (Superdex-200) of HAEC extracted
ulation of Rac elutes independently of eNOS (fraction 21  18 kDa,
s reacted with antibodies to Rac and eNOS simultaneously. (B) GST-
S in extracts of stably NOS-transfected HEK cells. Control samples (B
ed eNOS) with GST-bound glutathione-sepharose. (C) Puriﬁed eNOS
o GTP- vs. GDP-bound Rac is indistinguishable, and binding of eNOS
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other allosteric regulatory proteins. In combination with their
observations, our ﬁndings indicate that Rac may regulate the
activity of all major forms of NOS.
At least part of the association of Rac with NOS in cellular
extracts can be ascribed to a direct interaction, because puri-
ﬁed eNOS was bound by Rac-CA and by native (wild-type)
Rac (Fig. 3C). In addition, we observed consistently that bind-
ing of puriﬁed eNOS was equivalent for GDP-b-S-bound or
GTP-c-S-bound wild-type Rac, consistent with the description
by Kone et al. [19] of Rac/iNOS binding, and substantiallyFig. 4. Mediation by NO and/or O2 of Rac-dependent actin polymerizatio
substantially increases F-actin content as assessed by quantitation of rhodami
P < 0.005) by reducing intracellular O2 levels with MnTE-2-PyP
5+. Redu
combination with MnTE-2-PyP5+. Av-null indicates adenoviral vector co
ﬂuorescence, expression of Rac-CA results in a shift in the localization of F
predominantly associated with the plasma membrane (cortical actin, Ca). Assi
shows that the Rac-CA-induced shift in F-actin disposition is abrogated si
(MnTE-2-PyP5+), and that these eﬀects are not additive (n > 500 cells for eagreater for nucleotide-free Rac (Fig. 3C). Taken together with
our observations that NO production is potentiated by Rac-
CA and suppressed by Rac-DN, NSC and Rac knockdown,
equivalent binding of NOS by GDP-bound or GTP-bound
Rac suggests that activation/inactivation (by nucleotide ex-
change) of complexed Rac, rather than complex formation,
governs the function of Rac as an allosteric regulator of
NOS activity. Preferential binding of NOS by the nucleotide-
free form of Rac, which would be expected to exist only in
the presence of an active Rac GEF, may promote the regula-
tion of NOS by Rac in speciﬁc cellular compartments [20].n and cytoskeletal organization in HAEC. (A) Expression of Rac-CA
ne–phalloidin binding, and this increase is inhibited signiﬁcantly (n = 6;
cing NO production with L-NMMA has little eﬀect by itself or in
ntrol. (B) As revealed by the distribution of rhodamine–phalloidin
-actin from predominantly cytosolic in the form of stress ﬁbers (SF) to
gnment of cells to four categories based on relative content of Sf and Ca
gniﬁcantly either by inhibiting NOS (L-NMMA) or by removing O2
ch of the ﬁve conditions).
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actin-based cytoskeleton
Rac plays a prominent role in organization of the actin-based
cytoskeleton [21,22]. We evaluated the role of Rac-regulated
production of NO and O2 on cytoskeletal organization. As de-
scribed previously [10], expression of Rac-CA in endothelial
cells increased the cellular content of ﬁlamentous actin (F-ac-
tin), as assessed by quantitation of rhodamine–phalloidin bind-
ing (Fig. 4A). In addition, Rac-CA expression resulted in a
dramatic redistribution of rhodamine–phalloidin–decorated
actin ﬁlaments from cytosol (stress ﬁbers) to the inner surface
of the plasma membrane (cortical actin) (Fig. 4B). Treatment
with MnTE-2-PyP5+ substantially prevented the Rac-CA-in-
duced increase in F-actin content, whereas L-NMMA had no
signiﬁcant eﬀect by itself or in combination with MnTE-2-
PyP5+ (Fig. 4A). In contrast, both L-NMMA and MnTE-2-
PyP5+ signiﬁcantly reduced the Rac-CA-induced shift of
F-actin from stress ﬁbers to a cortical distribution, and their ef-
fects were not additive when assayed together (Fig. 4B). Thus,
regulation by Rac of the equilibrium between F-actin and
monomeric actin (actin polymerization) requires production
of O2 but not of NO, whereas the conﬁguration of the actin-
based cytoskeleton is dependent on the conjunct or concerted
action of both NO and O2 , as indicated by the non-additive
eﬀects on F-actin distribution of reducing the level of each
species.4. Discussion
4.1. Rac co-regulates NOS and NOX
Our ﬁndings delineate a revised perspective on redox-based
cellular signal transduction, in which Rac can function as a
common control element for NOS and NOX to provide for
coordination of NO- and ROS-mediated signals, in contrast
to the view that the interplay of NO and O2 is encompassed
by their chemical interaction. Because one or more forms of
NOS, NOX and Rac are present in most cell types, this role
may be of very general relevance. In addition, the regulation
of NOS by Rac expands the domains of cellular signals that
may inﬂuence NO production and of potential roles for NO
in diverse Rac-dependent cellular processes.
Coupled activation through Rac of NOX and NOS is consis-
tent with the ﬁnding that mechanical shear stress, a principal
determinant of eNOS activity, also activates Rac and increases
O2 production in endothelial cells [23], and it is known that
receptor ligands including VEGF, insulin and angiotensin
[1,2,4], as well as leukotriene B4 (our unpublished observa-
tions), can increase production of both NO and O2 . However,
we have found that other ligands including platelet-derived
growth factor can stimulate O2 production in the absence of
changes in levels of NO (unpublished observations).
4.2. Conjoint and independent eﬀects of NO and ROS in redox
regulation
Analysis in vitro suggests that S-nitrosothiol formation can
be promoted by combinatorial NO=O2 chemistry when NO
and O2 are generated simultaneously and at low levels [24],
and ROS (H2O2) can potentiate S-nitrosylation in vivo [25].
Thus, conjoint eﬀects of NO and ROS may be read out to a
signiﬁcant extent by enhanced S-nitrosylation of regulatoryand active sites Cys residues [1]. Delineating the common
and unique protein substrates of NO- and ROS-derived mod-
iﬁcations in the context of speciﬁc transduction pathways re-
mains a signiﬁcant challenge.Appendix A. Supplementary data
Supplementary data associated with this article can be
found, in the online version, at doi:10.1016/j.febslet.2008.
04.062.
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